Literature DB >> 17727988

Defining internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT.

Mian Xi1, Meng-Zhong Liu, Xiao-Wu Deng, Li Zhang, Xiao-Yan Huang, Hui Liu, Qiao-Qiao Li, Yong-Hong Hu, Ling Cai, Nian-Ji Cui.   

Abstract

BACKGROUND AND
PURPOSE: To define individualized internal target volume (ITV) for hepatocellular carcinoma using four-dimensional computed tomography (4DCT).
MATERIALS AND METHODS: Gross tumor volumes (GTVs) and clinical target volumes (CTVs) were contoured on all 10 respiratory phases of 4DCT scans in 10 patients with hepatocellular carcinoma. The 3D and 4D treatment plans were performed for each patient using two different planning target volumes (PTVs): (1) PTV(3D) was derived from a single CTV plus conventional margins; (2) PTV(4D) was derived from ITV(4D), which encompassed all 10 CTVs plus setup margins (SMs). The volumes of PTVs and dose distribution were compared between the two plans.
RESULTS: The average PTV volume of the 4D plans (328.4+/-152.2cm(3)) was less than 3D plans (407.0+/-165.6cm(3)). The 4D plans spared more surrounding normal tissues than 3D plans, especially normal liver. Compared with 3D plans, the mean dose to normal liver (MDTNL) decreased from 22.7 to 20.3Gy. Without increasing the normal tissue complication probability (NTCP), the 4D plans allowed for increasing the calculated dose from 50.4+/-1.3 to 54.2+/-2.6Gy, an average increase of 7.5% (range 4.0-16.0%).
CONCLUSIONS: The conventional 3D plans can result in geometric miss and include excess normal tissues. The 4DCT-based plans can reduce the target volumes to spare more normal tissues and allow dose escalation compared with 3D plans.

Entities:  

Mesh:

Year:  2007        PMID: 17727988     DOI: 10.1016/j.radonc.2007.07.021

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  21 in total

Review 1.  Charged-particle therapy for hepatocellular carcinoma.

Authors:  Heath D Skinner; Theodore S Hong; Sunil Krishnan
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  A single reference measurement can predict liver tumor motion during respiration.

Authors:  Jakub Cvek; Lukas Knybel; Lukas Molenda; Bretislav Otahal; Tomas Jonszta; Daniel Czerny; David Feltl
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-29

3.  SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques.

Authors:  Olivier Riou; Carmen Llacer Moscardo; Pascal Fenoglietto; Emmanuel Deshayes; Raphaël Tetreau; Jessica Molinier; Alexis Lenglet; Eric Assenat; Marc Ychou; Boris Guiu; Norbert Aillères; Ludovic Bedos; David Azria
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-06

4.  How does four-dimensional computed tomography spare normal tissues in non-small cell lung cancer radiotherapy by defining internal target volume?

Authors:  Tong Bai; Jian Zhu; Yong Yin; Jie Lu; Huazhong Shu; Lin Wang; Bo Yang
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

5.  Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy.

Authors:  Yoshiro Matsuo; Kenji Yoshida; Hideki Nishimura; Yasuo Ejima; Daisuke Miyawaki; Haruka Uezono; Takeaki Ishihara; Hiroshi Mayahara; Takumi Fukumoto; Yonson Ku; Masato Yamaguchi; Koji Sugimoto; Ryohei Sasaki
Journal:  J Radiat Res       Date:  2016-04-06       Impact factor: 2.724

6.  Analysis of the advantage of individual PTVs defined on axial 3D CT and 4D CT images for liver cancer.

Authors:  Fengxiang Li; Jianbin Li; Jun Xing; Yingjie Zhang; Tingyong Fan; Min Xu; Dongping Shang; Tonghai Liu; Jinlong Song
Journal:  J Appl Clin Med Phys       Date:  2012-11-08       Impact factor: 2.102

7.  Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinoma.

Authors:  Li Zhang; Mian Xi; Xiao-Wu Deng; Qiao-Qiao Li; Xiao-Yan Huang; Meng-Zhong Liu
Journal:  J Radiat Res       Date:  2012-06-28       Impact factor: 2.724

8.  Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis.

Authors:  Mian Xi; Li Zhang; Lei Zhao; Qiao-Qiao Li; Su-Ping Guo; Zi-Zhen Feng; Xiao-Wu Deng; Xiao-Yan Huang; Meng-Zhong Liu
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

9.  Dosimetric differences among volumetric modulated arc radiotherapy (RapidArc) plans based on different target volumes in radiotherapy of hepatocellular carcinoma.

Authors:  GuanZhong Gong; Yong Yin; YuJie Guo; TongHai Liu; JinHu Chen; Jie Lu; ChangSheng Ma; Tao Sun; Tong Bai; GuiFang Zhang; DengWang Li; RuoZheng Wang
Journal:  J Radiat Res       Date:  2012-08-21       Impact factor: 2.724

Review 10.  Therapeutic Strategies in HCC: Radiation Modalities.

Authors:  R Gallicchio; A Nardelli; P Mainenti; A Nappi; D Capacchione; V Simeon; C Sirignano; F Abbruzzi; F Barbato; M Landriscina; G Storto
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.